Laryngopharyngeal reflux in the light of current medical knowledge – a literature review
DOI:
https://doi.org/10.12775/JEHS.2025.79.59116Keywords
laryngopharyngeal reflux (LFR), proton pump inhibitors, pepsin inhibitorsAbstract
Introduction and aim of the work: Laryngopharyngeal reflux often occurs in daily otolaryngological clinical practice. Diagnostics and treatment of this disease are complex for clinicians. Proton pump inhibitors cause many adverse effects, so alternative therapeutic methods are required. This study aims to submit current medical knowledge about laryngopharyngeal reflux, including possible treatment options.
Materials and methods: The literature review of medical articles published between 2014 and 2024 was performed. These papers were accessed from the PubMed and Springer Nature Link databases. To find relevant articles, the following keywords were used: “laryngopharyngeal reflux”, “reflux laryngitis”, “proton pump inhibitors”, and “baclofen side effects”.
State of knowledge: Symptoms of laryngopharyngeal reflux can result in reduced quality of life. Laryngopharyngeal symptoms are not that specific. Patients often search for a reason for their complaints at different specialists. Treatment of this disease is usually based on the trial-and-error method and observing patients’ responses.
Summary: The accurate incidence of laryngopharyngeal reflux is not known. Various factors influence the occurrence of this disease. There are disparate opinions about using 24-hour pH monitoring as a gold standard; thus, other methods are sought. Proton pump inhibitors are the most common drugs used in the therapy, but their effectiveness is doubtful. More research should be done on the different methods of laryngopharyngeal reflux treatment. Pepsin inhibitors seem like an auspicious alternative, but there are too few studies on this subject.
References
1. Lechien JR, Mouawad F, Bobin F, Bartaire E, Crevier-Buchman L, Saussez S. Review of management of laryngopharyngeal reflux disease. Eur Ann Otorhinolaryngol Head Neck Dis. 2021;138(4):257-267. doi:10.1016/j.anorl.2020.11.002
2. Cui N, Dai T, Liu Y, et al. Laryngopharyngeal reflux disease: Updated examination of mechanisms, pathophysiology, treatment, and association with gastroesophageal reflux disease. World J Gastroenterol. 2024;30(16):2209-2219. doi:10.3748/wjg.v30.i16.2209
3. Muddaiah D, Prashanth V, Vybhavi MK, Srinivas V, Lavanya M. Role of Reflux Symptom Index and Reflux Finding Score in Diagnosing Laryngopharyngeal Reflux: A Prospective Study. Indian J Otolaryngol Head Neck Surg. 2023;75(2):777-783. doi:10.1007/s12070-023-03482-1
4. Pizzorni N, Ambrogi F, Eplite A, et al. Magnesium alginate versus proton pump inhibitors for the treatment of laryngopharyngeal reflux: a non-inferiority randomized controlled trial. Eur Arch Otorhinolaryngol. 2022;279(5):2533-2542. doi:10.1007/s00405-021-07219-0
5. Lechien JR, Bobin F. Variability and accuracy of multiple saliva pepsin measurements in laryngopharyngeal reflux patients. J Otolaryngol Head Neck Surg. 2023;52(1):66. Published 2023 Oct 4. doi:10.1186/s40463-023-00670-5
6. Puttamadaiah GM, Naik P. Usefulness of the Reflux Symptom Index and Reflux Finding Score in the Management of Laryngopharyngeal Reflux. Indian J Otolaryngol Head Neck Surg. 2024;76(6):5170-5175. doi:10.1007/s12070-024-04920-4
7. Kapil A, Acharya S, Bepari K, V D, Rajan S. Clinical Evaluation of Laryngopharyngeal Reflux and its Response to Proton Pump Inhibitors. Indian J Otolaryngol Head Neck Surg. 2023;75(2):409-415. doi:10.1007/s12070-022-03219-6
8. Suda A, Sikdar A, Nivsarkar S, Phatak S, Agarwal R. Reflux Symptom Index (RSI), Videolaryngostroboscopy and Voice Analysis: A Triad of Non-Invasive Tools to Study Treatment Outcomes of Laryngopharyngeal Reflux Disease (LPRD). Indian J Otolaryngol Head Neck Surg. 2024;76(1):250-261. doi:10.1007/s12070-023-04136-y
9. Kamal AN, Dhar SI, Bock JM, et al. Best Practices in Treatment of Laryngopharyngeal Reflux Disease: A Multidisciplinary Modified Delphi Study. Dig Dis Sci. 2023;68(4):1125-1138. doi:10.1007/s10620-022-07672-9
10. Shen H, Han Y, Wu D, et al. Trial of transcutaneous electrical acupoint stimulation in laryngopharyngeal reflux disease: study protocol for a randomized controlled trial. Trials. 2022;23(1):272. Published 2022 Apr 8. doi:10.1186/s13063-022-06193-0
11. Lechien JR, Bock JM, Carroll TL, Akst LM. Is empirical treatment a reasonable strategy for laryngopharyngeal reflux? A contemporary review. Clin Otolaryngol. 2020;45(4):450-458. doi:10.1111/coa.13518
12. R C, Chutke A, Jadhav R, Ramanathan S, Shamkant S. Salivary pH testing in Laryngopharyngeal Reflux Disease. Indian J Otolaryngol Head Neck Surg. 2024;76(6):5812-5817. doi:10.1007/s12070-024-05109-5
13. Saha J, Biswas D, Chakraborty R, Chatterjee A, Das A. The importance of laryngoscopic findings as predictors of the treatment outcomes of laryngopharyngeal reflux: a retrospective review of 143 cases. The Egyptian Journal of Otolaryngology. 2022;38(1). doi:https://doi.org/10.1186/s43163-022-00260-8
14. Stinnett S, Dhillon V, Akst L. Laryngopharyngeal Reflux: Current Concepts on Etiology and Pathophysiology and Its Role in Dysphagia. Current Otorhinolaryngology Reports. 2018;6(2):196-202. doi:https://doi.org/10.1007/s40136-018-0192-6
15. Li Y, Xu G, Zhou B, et al. Effects of acids, pepsin, bile acids, and trypsin on laryngopharyngeal reflux diseases: physiopathology and therapeutic targets. Eur Arch Otorhinolaryngol. 2022;279(6):2743-2752. doi:10.1007/s00405-021-07201-w
16. Krause AJ, Walsh EH, Weissbrod PA, Taft TH, Yadlapati R. An update on current treatment strategies for laryngopharyngeal reflux symptoms. Ann N Y Acad Sci. 2022;1510(1):5-17. doi:10.1111/nyas.14728
17. Kowalik K, Krzeski A. The role of pepsin in the laryngopharyngeal reflux. Otolaryngol Pol. 2017;71(6):7-13. doi:10.5604/01.3001.0010.7194
18. Morice D, Elhassan HA, Myint-Wilks L, et al. Laryngopharyngeal reflux: is laparoscopic fundoplication an effective treatment?. Ann R Coll Surg Engl. 2022;104(2):79-87. doi:10.1308/rcsann.2021.0046
19. Fossmark R, Ness-Jensen E, Sørdal Ø. Is empiric proton pump inhibition in patients with symptoms of extraesophageal gastroesophageal reflux justified?. BMC Gastroenterol. 2023;23(1):303. Published 2023 Sep 6. doi:10.1186/s12876-023-02945-7
20. Prakash MD, T LN, Joy L. Reflux Finding Score and Reflux Symptom Index Potential Indicators for Diagnosis and Management of Laryngopharyngeal Reflux Disease. Indian J Otolaryngol Head Neck Surg. 2024;76(4):3239-3244. doi:10.1007/s12070-024-04657-0
21. Yun JM, Kim KW, Kim S, So YK. Salivary pepsin as an independent predictor of treatment response for laryngopharyngeal reflux: prospective cohort study with multivariate analysis. Sci Rep. 2023;13(1):22893. Published 2023 Dec 21. doi:10.1038/s41598-023-50014-6
22. Lechien JR. Minimum Effective Duration of Laryngopharyngeal Reflux Disease Treatment: A Prospective Study. Otolaryngol Head Neck Surg. 2024;171(4):1114-1122. doi:10.1002/ohn.878
23. Yu L, Li R, Du L, Zhao Y. The diagnostic value of pepsin concentration in saliva for laryngopharyngeal reflux disease. Eur Arch Otorhinolaryngol. 2022;279(12):5783-5789. doi:10.1007/s00405-022-07472-x
24. Sahay N, Soni A, Soni S, Modwal A, Sharma MP. Exploring the Substantive Significance of Laryngoscopic Observations as Reliable Prognostic Indicators for the Therapeutic Efficacy in Cases of Laryngopharyngeal Reflux. Indian J Otolaryngol Head Neck Surg. 2024;76(2):1660-1666. doi:10.1007/s12070-023-04379-9
25. Stewart SJ, Wee JO. Antireflux Surgery and Laryngopharyngeal Reflux. Current Otorhinolaryngology Reports. 2016;4(1):63-66. doi:https://doi.org/10.1007/s40136-016-0104-6
26. Luebke KE, Samuels TL, Johnston N. The Role of Pepsin in LPR: Will It Change Our Diagnostic and Therapeutic Approach to the Disease? Current Otorhinolaryngology Reports. 2016;4(1):55-62. doi:https://doi.org/10.1007/s40136-016-0106-4
27. Kim SI, Lee YC, Cha W, et al. Efficacy and safety of fexuprazan in patients with symptoms and signs of laryngopharyngeal reflux disease: a randomized clinical trial. Eur Arch Otorhinolaryngol. 2024;281(11):5873-5883. doi:10.1007/s00405-024-08877-6
28. Huestis MJ, Keefe KR, Kahn CI, Tracy LF, Levi JR. Alternatives to Acid Suppression Treatment for Laryngopharyngeal Reflux. Ann Otol Rhinol Laryngol. 2020;129(10):1030-1039. doi:10.1177/0003489420922870
29. Eryilmaz A, Basal Y, Gunel C, et al. Awareness and daily practices of family physicians and trainees towards laryngopharyngeal reflux. Eur Arch Otorhinolaryngol. 2016;273(12):4377-4384. doi:10.1007/s00405-016-4180-5
30. Ertzgaard P, Campo C, Calabrese A. Efficacy and safety of oral baclofen in the management of spasticity: A rationale for intrathecal baclofen. J Rehabil Med. 2017;49(3):193-203. doi:10.2340/16501977-2211
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Stella Mieruszyńska, Jagoda Mikołajczyk, Maciej Gołębski, Wojciech Nowak, Zuzanna Kukla, Paulina Krzemińska, Mirosław Sawicki, Izabela Sadowska, Jakub Włosiański, Sebastian Musialik

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 166
Number of citations: 0